Literature DB >> 3829422

Human inter-alpha-trypsin inhibitor and immunologically related inhibitors investigated by quantitative immunoelectrophoresis. II. Pathological conditions.

L Odum, G Hansen-Nord, I Byrjalsen.   

Abstract

Inter-alpha-trypsin inhibitor (I alpha I) and the immunologically related prealbumin-like-migrating proteinase inhibitor (pA-PI) were investigated by crossed immunoelectrophoresis in sera from 68 persons with myocardial infarction, neoplastic diseases, inflammatory diseases, collagenosis, cirrhosis of the liver or uremia. The concentration of pA-PI in serum increased during each of these diseases (p less than 0.01). The concentration of I alpha I was significantly decreased in patients with cirrhosis (p less than 0.01). In day to day studies of a patient with myocardial infarction, a patient with erysipelas and a postoperative patient the concentration of I alpha I was low normal to decreased in the first days of the conditions and increased thereafter to high normal values. A comparison of the concentration of pA-PI with the excretion of the immunologically identical urinary proteinase inhibitor (UPI) showed that the excretion could not be caused by simple overflow of pA-PI in the kidney. The excretion of UPI followed closely the acute-phase-response, as measured by serum C-reactive protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829422     DOI: 10.1016/0009-8981(87)90450-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Distribution and localization of inter-alpha-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohistochemical study.

Authors:  E Yoshida; H Sumi; H Tsushima; M Maruyama; H Mihara
Journal:  Inflammation       Date:  1991-02       Impact factor: 4.092

2.  Human inter-alpha-inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins.

Authors:  M Daveau; P Rouet; M Scotte; L Faye; M Hiron; J P Lebreton; J P Salier
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

3.  Immunohistochemical demonstration of bikunin, a light chain of inter-alpha-trypsin inhibitor, in human brain tumors.

Authors:  E Yoshida; M Maruyama; M Sugiki; H Mihara
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

4.  Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine.

Authors:  F Atmani; S R Khan
Journal:  Urol Res       Date:  1995
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.